Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,652 | -41,964 | -183,101 | -136,964 | -97,316 |
| Depreciation Amortization | 18,109 | 8,907 | 34,158 | 25,187 | 16,544 |
| Accounts receivable | -3,129 | 9,872 | -17,668 | -8,494 | -4,724 |
| Accounts payable and accrued liabilities | 4,082 | -10,297 | 22,536 | 6,884 | 1,484 |
| Other Working Capital | -5,716 | -6,862 | 44,890 | -5,411 | -4,633 |
| Other Operating Activity | 17,112 | 10,290 | 34,495 | 31,746 | 23,952 |
| Operating Cash Flow | $-50,194 | $-30,054 | $-64,690 | $-87,052 | $-64,693 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,377 | -772 | -3,100 | -2,504 | -1,690 |
| Purchase Of Investment | -73,006 | -25,236 | -116,591 | -84,111 | -43,455 |
| Sale Of Investment | 52,988 | 28,288 | 192,870 | 160,769 | 118,357 |
| Investing Cash Flow | $-21,395 | $2,280 | $73,179 | $74,154 | $73,212 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 8,274 | 8,274 | 8,274 |
| Debt Repayment | N/A | N/A | -8,274 | -8,274 | -8,274 |
| Common Stock Issued | N/A | N/A | -859 | N/A | -1,160 |
| Other Financing Activity | -25 | -1,101 | 0 | -1,255 | 0 |
| Financing Cash Flow | $-25 | $-1,101 | $-859 | $-1,255 | $-1,160 |
| Beginning Cash Position | 151,570 | 151,570 | 143,940 | 143,940 | 143,940 |
| End Cash Position | 79,956 | 122,695 | 151,570 | 129,787 | 151,299 |
| Net Cash Flow | $-71,614 | $-28,875 | $7,630 | $-14,153 | $7,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,194 | -30,054 | -64,690 | -87,052 | -64,693 |
| Capital Expenditure | -1,377 | -772 | -3,100 | -2,504 | -1,690 |
| Free Cash Flow | -51,571 | -30,826 | -67,790 | -89,556 | -66,383 |